Search

Search Constraints

You searched for: Author/Creator Christou, Soteroula

Search Results

1. A novel mutation in the erythroid transcription factor KLF1 is likely responsible for ameliorating β‐thalassemia major. Issue 10 (24th June 2019)

2. Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial. Issue 6 (June 2020)

3. Gene Therapy Getting Personal: Mutation-Specific Editing and Gene Addition Strategies for β-Thalassaemia. (2nd November 2019)

4. KLF10 gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients. (October 2012)